RxDoctor Payments Data

Kimberly Valenti, NP

Nurse Practitioner · Spartanburg, SCNPI 1255716775

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,596 of the $13,952 with a category attached, or 75.9%. 30 manufacturers reported payments, led by Boston Scientific at 24.1% of the total. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,952in general payments, 2019–2025

Across 490 payments — averaging $28.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$3K
  • Abbott$3K
  • Edwards Lifesciences$3K
  • Abiomed$351
  • Shockwave Medical, Inc$328
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$3,35524%
  • Food & beverage$10,59676%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,952 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$19,254
Medicare patients
202
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$36,319
ClopidogrelClopidogrel Bisulfate130$1,241
Pantoprazole Sodium48$565
Losartan Potassium14$101
Metoprolol Tartrate18$68
Furosemide18$41
Carvedilol13$32
Amlodipine Besylate12$17

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$36,31950 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →